Pre-Surgery Image-Guided Radiotherapy for Sarcoma Patients Reduces Long-Term Side Effects
By MedImaging International staff writers Posted on 15 Feb 2015 |
Soft Tissue Sarcomas (STS) are relatively rare but deadly cancerous tumors of fat, muscles, nerves, tendons, blood vessels, or connective tissues. Standard treatment includes radiotherapy of the sarcoma which may result in damage to healthy tissue and long-term side effects.
In order to address this issue, a multiyear, multi-institution phase 2 clinical trial was conducted over three years at 18 medical centers across the United States (US) by the US Radiation Therapy Oncology Group (RTOG)/NRG Oncology Group. The trial studied more than 100 patients with STS of the extremities. Under the trial, image-guided radiotherapy was administered, prior to tumor removal surgery, to a much smaller area than is standard for treating STS. To achieve this, a series of images of the tumor were taken every day, and digitally integrated with previous scans. This enabled the researchers to determine a custom tailored radiation dose, to minimize exposure to healthy tissue adjacent to the tumor.
Assessments two years after the radiotherapy treatment showed that long-term side effects were only 10.5%. Patients in a previous study, who received radiation to a larger target area, showed long-term side effects of less than 37%.
The study was published in the February 10, 2015, online issue of the Journal of Clinical Oncology and showed that the new treatment damages less healthy tissue and reduces long-term side effects, while survival rates remained unchanged. The findings were considered a significant advance in clinical cancer research and could establish a new standard for treatment of STS.
Dr. Dian Wang, lead author of the paper, professor of Radiation Oncology at Rush University Medical Center (Chicago, IL, USA), and chair of the NRG Oncology Group commented, “This study proves that we are able to use this modern technology—image-guided radiotherapy—to irradiate smaller target volumes (less normal tissue included) and reduce long term side effects in extremity sarcoma patients compared with conventional radiotherapy.”
Related Links:
Rush University Medical Center
In order to address this issue, a multiyear, multi-institution phase 2 clinical trial was conducted over three years at 18 medical centers across the United States (US) by the US Radiation Therapy Oncology Group (RTOG)/NRG Oncology Group. The trial studied more than 100 patients with STS of the extremities. Under the trial, image-guided radiotherapy was administered, prior to tumor removal surgery, to a much smaller area than is standard for treating STS. To achieve this, a series of images of the tumor were taken every day, and digitally integrated with previous scans. This enabled the researchers to determine a custom tailored radiation dose, to minimize exposure to healthy tissue adjacent to the tumor.
Assessments two years after the radiotherapy treatment showed that long-term side effects were only 10.5%. Patients in a previous study, who received radiation to a larger target area, showed long-term side effects of less than 37%.
The study was published in the February 10, 2015, online issue of the Journal of Clinical Oncology and showed that the new treatment damages less healthy tissue and reduces long-term side effects, while survival rates remained unchanged. The findings were considered a significant advance in clinical cancer research and could establish a new standard for treatment of STS.
Dr. Dian Wang, lead author of the paper, professor of Radiation Oncology at Rush University Medical Center (Chicago, IL, USA), and chair of the NRG Oncology Group commented, “This study proves that we are able to use this modern technology—image-guided radiotherapy—to irradiate smaller target volumes (less normal tissue included) and reduce long term side effects in extremity sarcoma patients compared with conventional radiotherapy.”
Related Links:
Rush University Medical Center
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection